The Features of the Course and Outcomes of HIV Infection Diagnosed at the Stage of Pronounced Immunosuppression
https://doi.org/10.51523/2708-6011.2019-16-4-3
Abstract
Objective: to present the features of the course and outcomes of HIV infection diagnosed at the stage of pronounced immunosuppression.
Material and methods. Based on the primary CD4 + T-lymphocytes count, 492 patients living with HIV were divided into 2 groups: group 1 - 220 patients (CD4 + TL less than or equal to 350 cells/μl), group 2 - 272 patients (CD4 + TL more than 350 cells/µl). The statistical analysis was performed using the package «Statisticа» v.10.
Results. Among the patients of the first group there were more men than in the second group: 136 (61.8 %) and 125 (46 %), p < 0.001, respectively; more patients in HIV clinical stages 3 and 4 - 52.7 % and 27.6 %, p < 0.05; more ART patients: 208 (94.5 %) and 148 (54.4 %) p < 0.001, respectively. The levels of T-helpers and IRI (immunoregulatory index) in the patients of group 2 in the follow-up dynamics remained significantly higher compared with those of the patients of group 1. The incidence of tuberculosis was higher in group 1: 33 (15 %) and 15 (5.5 %), respectively, p < 0.05. In the first group, 23 (10.5 %) patients died, in the second - 9 (3.3 %), p < 0.003.
Conclusion. HIV-infection at the stage of pronounced immunosuppression was diagnosed in 220 patients - 44.7 % (95 % CI: 40.4-49.1) of the cases. Severe immunosuppression in the primarily diagnosed patients was associated with the presence of HIV clinical stages 3 and 4 (OR - 2.9; 95 % CI: 2.0-4.3), higher incidence rates of tuberculosis (OR - 3.02; 95 % CI: 1.6-5.7) and fatal outcomes (OR - 3.4; 95 % CI: 1.5-7.5), a slower increase in T-helpers and IRI counts.
About the Author
N. V. MatsiyeuskayaBelarus
Matsiyeuskaya N.V., MD, PhD, Head of the Department of Infectious Diseases of the educational institution «Grodno State Medical University».
References
1. HIV/AIDS surveillance in Europe 2017 - 2016 data [Electronic resource]. Available from: https://www.ecdc.europa.eu/en/ publications-data/hivaids-surveillance-europe-2017-2016-data.
2. Cuzin L, Yazdanpanah Y, Huleux T, Cotte L, Pugliese P, Allavena C et al. Dat'AIDS Study Group No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France. HIV Med. 2018;Mar;19(3):238-42. doi:10.1111/hiv.12545.Epub 2017Aug18.
3. Noble G, Okpo E, Tonna I, & Fielding S. Factors associated with late HIV diagnosis in North-East Scotland: a six-year retrospective study. Public Health. 2016;139:36-43. https://doi.org/10.1016/ j.puhe.2016.06.007.
4. Darling KEA., Hachfel A, Cavassini M, Kirk O, Furrer H, Wandeler G. Late presentation to HIV care despite good access to health services: current epidemiological trends and how to do better. Swiss Med Wkly. 2016;146:w14348. doi:10.4414/smw.2016.14348.
5. Celesia BM., Castronuovo D, Pinzone MR., Bellissimo F, Mughini MT, Lupo G, et al. Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily. European Review for Medical and Pharmacological Sciences 2013;17:2218-24.
6. Mocroft A, Lundgren JD, Sabin ML, Monforte A, Brockmeyer N, Casabona J, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoSMed. 2013;10:e1001510.
7. Fuster-Ruiz de Apodacaa MJ., Molerob F, Nouvilasb E, Arazob P, Dalmau D. Determinants of late diagnosis of HIV infection in Spain. Psychosocial Intervention. 2014;23:177-85.
8. MacCarthy S, Brignol S, Reddy M, Nunn A, Dourado I. Making the invisible, visible: a cross-sectional study of late presentation to HIV/AIDS services among men who have sex with men from a large urban center of Brazil. BMC Public Health. 2014;14:1313. doi:10.1186/1471-2458-14-1313.
9. Панкова ЕД., Никульшина ЛЛ. Поздняя диагностика ВИЧ-инфекции у молодого пациента. Клинический случай. Вестник СМУС74. 2018;2(21). URL: https://cyberleninka.ru/article /n/pozdnyaya-diagnostika-vich-infektsii-u-molodogo-patsienta-klini-cheskiy-sluchay.
10. Матиевская НВ. Ко-инфекция ВИЧ/ВГС: этиология, эпидемиология, патогенез, клиника, диагностика, лечение: монография. Гродно, Беларусь: ГрГМУ; 2013. 352 с.
11. Raben D, Sullivan AK, Mocroft A, Kutsyna G, Hadžiosmanović V, Vassilenko A, Chkhartisvili N, Mitsura V. et al. Improving the evidence for indicator condition guided HIV testing in Europe: results from the HIDES II study – 2012-2015 PLoS One. 2019;14(8): e0220108. doi:10.1371/journal.pone.0220108.
Review
For citations:
Matsiyeuskaya N.V. The Features of the Course and Outcomes of HIV Infection Diagnosed at the Stage of Pronounced Immunosuppression. Health and Ecology Issues. 2019;(4):16-22. (In Russ.) https://doi.org/10.51523/2708-6011.2019-16-4-3